PANTRELLO Trademark
Trademark Overview
On Monday, September 28, 2015, a trademark application was filed for PANTRELLO with the United States Patent and Trademark Office. The USPTO has given the PANTRELLO trademark a serial number of 79175553. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, October 30, 2024. This trademark is owned by Novartis AG. The PANTRELLO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
General Information
| Serial Number | 79175553 |
| Word Mark | PANTRELLO |
| Filing Date | Monday, September 28, 2015 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Wednesday, October 30, 2024 |
| Registration Number | 4924894 |
| Registration Date | Tuesday, March 29, 2016 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 12, 2016 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, October 14, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Friday, November 6, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, November 10, 2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, November 12, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 17, 2015 | APPLICATION FILING RECEIPT MAILED |
| Friday, December 4, 2015 | ASSIGNED TO EXAMINER |
| Monday, December 7, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 24, 2015 | NOTICE OF PUBLICATION |
| Tuesday, January 12, 2016 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 29, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, April 28, 2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Friday, April 29, 2016 | FINAL DISPOSITION PROCESSED |
| Friday, April 29, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, August 4, 2016 | NOTIFICATION PROCESSED BY IB |
| Friday, October 14, 2022 | CANCELLED SECTION 71 |
| Wednesday, June 14, 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, July 21, 2023 | INVALIDATION PROCESSED |
| Saturday, July 22, 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Sunday, August 13, 2023 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Friday, November 15, 2024 | DEATH OF INTERNATIONAL REGISTRATION |
